πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,435 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11702419

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11696893

Preparation comprising vonoprazan

Takeda Pharmaceutical Company Limited Β· Granted Tue Jul 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11690839

Treatment of idiopathic pulmonary fibrosis

TAKEDA GMBH Β· Granted Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11684632

Maribavir isomers, compositions, methods of making and methods of using

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11685780

Single domain antigen binding domains that bind human Trop2

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11672831

Use of adipose tissue-derived stromal stem cells in treating fistula

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11670409

Method and apparatus for providing a pharmacokinetic drug dosing regiment

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11666594

Antibody-drug conjugates comprising a cyclic dinucleotide

Takeda Pharmaceutical Company Limited Β· Granted Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11660318

Use of adipose tissue-derived stromal stem cells in treating fistula

Takeda Pharmaceutical Company Limited Β· Granted Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11660328

GLP-2 analogs and peptibodies for administration before, during or after surgery

Takeda Pharmaceutical Company Limited Β· Granted Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11661593

Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11655241

Heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11648304

Zika vaccines and immunogenic compositions, and methods of using the same

Takeda Vaccines, Inc. Β· Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11649206

Method for producing pyrrole compound

Takeda Pharmaceutical Company Limited Β· Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11613586

Methods and materials for assessing response to plasmablast- and plasma cell-depleting the

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11603519

T-cell receptor

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11596671

Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with in

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11596688

Predicting outcome of treatment with an anti-Ξ±4Ξ²7 integrin antibody

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11597928

Nucleic acid complex

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11590221

Dengue vaccine unit dose and administration thereof

Takeda Vaccines, Inc. Β· Granted Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11584737

Heterocyclic compound

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11583563

Adeno-associated virus formulations

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11583526

Treatment of prostate cancer

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11576863

Formulation of an antibody and use thereof

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted